$29.04
-0.44-1.49%
At close: Nov 13, 4:00 PM EST
$28.21
-0.83-2.86%
After Hours: Nov 13, 4:41 PM EST
Adaptive Biotechnologies Corp
ADPTNASDAQ
The average analyst price target for Adaptive Biotechnologies is $24.14, 14.4% below the current price. Of 7 analysts, 7 rate it Buy. Targets range from $10 to $35. The latest change came on Nov 10, 2026, when Guggenheim raised its price target on Adaptive Biotechnologies from $32 to $34 and kept a Buy rating.
Price Target Range — 12 Quarters
Analyst Consensus — 7 Analysts
Rating Trend — Last 9 Months
